The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.

Long COVID prevalence and burden continue to decrease among health care workers however, some still experience everyday life restrictions.

Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...

Patients with autosomal dominant polycystic kidney disease and their clinicians need to be alert for diabetes, infection, and clotting.

COVID-19 is associated with accelerated decline in kidney function, especially after hospitalization, according to study findings.